Overview of JustBreathe
Just Breathe is a medical device company developing the first-ever airflow-guided breathwork device for mental health management. Founded by Greg Calderiso following his personal health transformation, we’ve progressed from concept to clinical validation in under two years. With $165,000 in non-dilutive funding and investment, we’ve completed a 40-patient clinical study at Women & Infants Hospital demonstrating significant stress reduction and improved heart rate variability.
Our Ask
We seek connections with impact investors and philanthropic partners interested in funding innovative mental health and wellness solutions. Just Breathe is raising $750,000 in pre-seed funding to complete critical milestones, including industrial design refinement, market validation, and preparation for commercial launch.
Product or Service
Just Breathe is a patent-pending handheld device that uses gentle airflow cues to guide users through scientifically validated breathing patterns. Unlike apps or visual guides that require cognitive load, our device creates an intuitive, distraction-free experience – air on the lips prompts inhalation, air on the nose prompts exhalation. The device includes real-time biometric monitoring (heart rate variability) and connects to a smartphone app for progress tracking. Clinical data shows 25% stress reduction and 87% of users reporting improved anxiety management.
Company Impact
Our innovation addresses a critical gap in mental health treatment, particularly for the 700,000+ women annually experiencing perinatal mood and anxiety disorders. Key impacts include:
- A non-pharmacological solution is ideal for pregnancy/postpartum when medication concerns are high
- Clinically proven 25% physiological stress reduction in a hospital study
- 85% user satisfaction with an unoptimized prototype
- Potential applications across multiple populations: students, PTSD sufferers, workplace wellness
- Addresses the mental health provider shortage by offering accessible, immediate intervention
Primary Audience
Primary: Perinatal women (pregnancy through postpartum) experiencing mood and anxiety disorders.
Secondary markets:
- Partners/spouses of perinatal women
- Students and teens with test anxiety or panic disorders
- Military veterans and first responders with PTSD
- Corporate wellness programs addressing workplace stress
- The general population seeking non-pharmaceutical anxiety management
Partnership Opportunity
- Healthcare systems for clinical pilots and distribution
- Mental health clinics and perinatal care providers
- Corporate wellness programs
- School systems (following NYC’s mandatory mindful breathing initiative)
- Research institutions for expanded clinical validation
- Disability advocacy organizations
- Manufacturing partnerships with medical device companies
- Distribution through wellness practitioners and healthcare providers
Funding Needs
We seek connections with impact investors and philanthropic partners interested in funding innovative mental health and wellness solutions. Just Breathe is raising $750,000 in pre-seed funding to complete critical milestones, including industrial design refinement, market validation, and preparation for commercial launch.